HomeCompareSVOL vs JNJ

SVOL vs JNJ: Dividend Comparison 2026

SVOL yields 23.12% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SVOL wins by $58.0K in total portfolio value
10 years
SVOL
SVOL
● Live price
23.12%
Share price
$15.36
Annual div
$3.55
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$88.3K
Annual income
$9,281.66
Full SVOL calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SVOL vs JNJ

📍 SVOL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSVOLJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SVOL + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SVOL pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SVOL
Annual income on $10K today (after 15% tax)
$1,965.16/yr
After 10yr DRIP, annual income (after tax)
$7,889.41/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SVOL beats the other by $3,903.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SVOL + JNJ for your $10,000?

SVOL: 50%JNJ: 50%
100% JNJ50/50100% SVOL
Portfolio after 10yr
$59.3K
Annual income
$6,985.53/yr
Blended yield
11.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SVOL
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SVOL buys
0
JNJ buys
0
No recent congressional trades found for SVOL or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSVOLJNJ
Forward yield23.12%2.13%
Annual dividend / share$3.55$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$88.3K$30.3K
Annual income after 10y$9,281.66$4,689.40
Total dividends collected$53.9K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SVOL vs JNJ ($10,000, DRIP)

YearSVOL PortfolioSVOL Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,012$2,311.95$10,592$272.30+$2.4KSVOL
2$16,734$2,811.49$11,289$357.73+$5.4KSVOL
3$21,285$3,379.23$12,123$472.89+$9.2KSVOL
4$26,792$4,016.97$13,141$629.86+$13.7KSVOL
5$33,393$4,725.48$14,408$846.81+$19.0KSVOL
6$41,235$5,504.42$16,021$1,151.60+$25.2KSVOL
7$50,473$6,352.41$18,122$1,588.22+$32.4KSVOL
8$61,274$7,267.00$20,930$2,228.20+$40.3KSVOL
9$73,808$8,244.83$24,792$3,191.91+$49.0KSVOL
10$88,256$9,281.66$30,274$4,689.40+$58.0KSVOL

SVOL vs JNJ: Complete Analysis 2026

SVOLStock

The Simplify Volatility Premium ETF (SVOL) seeks to provide investment results, before fees and expenses, that correspond to approximately one-fifth to three-tenths (-0.2x to -0.3x) the inverse of the performance of the Cboe Volatility Index (VIX) short-term futures index while also seeking to mitigate extreme volatility. We believe many traditional sources of income are failing to meet investor needs in today’s low yield environment. SVOL aims to provide an attractive income stream and source of diversification while seeking to avoid risks inherent in other income-producing asset classes. The fund’s short VIX position provides investors an optimized exposure for monetizing the premium in the VIX futures market. A modest option overlay budget is then deployed into VIX call options to help protect against adverse moves in VIX.

Full SVOL Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SVOL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SVOL vs SCHDSVOL vs JEPISVOL vs OSVOL vs KOSVOL vs MAINSVOL vs ABBVSVOL vs MRKSVOL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.